These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 4480665)

  • 1. Cortisol metabolism in liver cirrhosis.
    Scavo D; Cugini P; Di Lascio G; Lupi A; Rossi G
    Folia Endocrinol; 1974 Dec; 27(6pt2):670-7. PubMed ID: 4480665
    [No Abstract]   [Full Text] [Related]  

  • 2. The metabolic clearance rate of cortisol in normal subjects and in various disease states.
    Scavo D; Cugini P; Di Lascio G
    J Nucl Med Allied Sci; 1978; 22(3):113-23. PubMed ID: 739279
    [No Abstract]   [Full Text] [Related]  

  • 3. [Aspects of cortisol metabolism in liver diseases].
    Della Casa L; Boni M
    Endocrinol Sci Cost; 1967 Nov; 29(5):344-53. PubMed ID: 5616116
    [No Abstract]   [Full Text] [Related]  

  • 4. [Data on the metabolism of cortisol in obesity].
    Scavo D; Cugini P; Di Lascio G
    Folia Endocrinol; 1974 Dec; 27(6pt2):589-603. PubMed ID: 4480657
    [No Abstract]   [Full Text] [Related]  

  • 5. The daily rhythm of cortisolemia in hepatic cirrhosis.
    Ruzyllo E; Dzieniszewski J; Milewski B; Krygier T
    Mater Med Pol; 1973; 5(1):9-16. PubMed ID: 4774849
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of diphenylhydantoin on cortisol kinetics in humans.
    Choi Y; Thrasher K; Werk EE; Sholiton LJ; Olinger C
    J Pharmacol Exp Ther; 1971 Jan; 176(1):27-34. PubMed ID: 4936459
    [No Abstract]   [Full Text] [Related]  

  • 7. Half-life time or clearance of indocyanine green in patients with liver disease.
    Gilmore IT; Marigold JH; Thompson RP
    Hepatogastroenterology; 1982 Apr; 29(2):55-7. PubMed ID: 7084884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in metabolic properties among cortisol, prednisolone, and dexamethasone in liver and renal diseases: accelerated metabolism of dexamethasone in renal failure.
    Kawai S; Ichikawa Y; Homma M
    J Clin Endocrinol Metab; 1985 May; 60(5):848-54. PubMed ID: 3980669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Handling of drugs by cirrhotic patients].
    Danan G; Pariente A
    Rev Prat; 1986 Sep; 36(39):2298-308. PubMed ID: 3809928
    [No Abstract]   [Full Text] [Related]  

  • 10. [The liver and hormonal steroids. Physiological and pathological problems].
    Bercovici JP; Mauvais-Jarvis P
    Pathol Biol (Paris); 1972 Mar; 20(5):305-14. PubMed ID: 4556215
    [No Abstract]   [Full Text] [Related]  

  • 11. Fractional clearance of bromosulfonephthalein and metabolic clearance of antipyrine. Correlative study in liver diseases.
    Couet C; Brissot P; Messner M; Delamaire D; Gie S; Bourel M
    Ann Gastroenterol Hepatol (Paris); 1984; 20(1):1-6. PubMed ID: 6529154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hepatic clearance of 99mTc-p-butyl HIDA in liver diseases. Correlations with routine hematochemical parameters of liver function].
    Custro N; De Francisci MC; Patanella I; Scafidi V; Indovina I
    Minerva Med; 1984 Nov; 75(42):2527-32. PubMed ID: 6083507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug disposition in liver disease.
    Fruncillo RJ
    Am Fam Physician; 1982 Dec; 26(6):167-9. PubMed ID: 7148640
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of bile acids and some biliary excreted drugs on the metabolism of cortisol.
    Gerdes H; Riemenschneider H; Littmann KP
    Acta Endocrinol Suppl (Copenh); 1973; 173():10. PubMed ID: 4542050
    [No Abstract]   [Full Text] [Related]  

  • 15. The clearance of a tracer dose of cholic acid in liver cirrhosis.
    Borel GA; Magnenat P
    Helv Med Acta; 1973 Sep; 37(2):129-35. PubMed ID: 4748921
    [No Abstract]   [Full Text] [Related]  

  • 16. Normal metabolism of morphine in cirrhosis.
    Patwardhan RV; Johnson RF; Hoyumpa A; Sheehan JJ; Desmond PV; Wilkinson GR; Branch RA; Schenker S
    Gastroenterology; 1981 Dec; 81(6):1006-11. PubMed ID: 7286578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of fibrinogen in cirrhosis of the liver.
    Tytgat GN; Collen D; Verstraete M
    South Med J; 1971 Oct; 64(10):1690-701. PubMed ID: 5125556
    [No Abstract]   [Full Text] [Related]  

  • 18. [Production and metabolic clearance rates of cortisol in primary hypothyroidism (author's transl)].
    Linquette M; Lefebvre J; Racadot A; Cappoen JP; Benoit G
    Ann Endocrinol (Paris); 1973; 34(4):427-9. PubMed ID: 4360564
    [No Abstract]   [Full Text] [Related]  

  • 19. [Fatty acid and triglyceride turnover in patients with liver cirrhosis].
    Sandhofer F; Sailer S; Braunsteiner H
    Wien Klin Wochenschr; 1966 Oct; 78(43):731-3. PubMed ID: 5996745
    [No Abstract]   [Full Text] [Related]  

  • 20. Unresponsiveness of hepatic nitrogen metabolism to glucagon infusion in patients with cirrhosis: dependence on liver cell failure.
    Fabbri A; Marchesini G; Bianchi G; Bugianesi E; Bortoluzzi L; Zoli M; Pisi E
    Hepatology; 1993 Jul; 18(1):28-35. PubMed ID: 8325618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.